Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Brainstorm Cell Stock Price, Quotes and Forecasts | NASDAQ:BCLI | Benzinga

Q: What sector and industry does Brainstorm Cell (BCLI) operate in?

Brainstorm Cell is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Explore Brainstorm Cell stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for BCLI.

Open	$1.06
Close	-
Volume / Avg.	182.16K / 1.32M
Day Range	$1.05 - $1.15
52 Wk Range	0.72 - 6.45
Market Cap	$9.09M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	48
Short Interest	6.45%
Days to Cover	1.08

Recent News

Partner Content

Presenting Encouraging Data, Acquiring Licenses, Issuing Patents And More – BioRestorative's Inroads Bringing Its Stem Cell Therapies To Market

Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket

Shares of Biophytis S.A. (NASDAQ: BPTS) rose sharply in today’s pre-market trading after reporting FY23 results.

Avi Kapoor

Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$1.06
Close	-
Volume / Avg.	182.16K / 1.32M
Day Range	$1.05 - $1.15
52 Wk Range	0.72 - 6.45
Market Cap	$9.09M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	48
Short Interest	6.45%
Days to Cover	1.08

About Brainstorm Cell Therapeutics, Inc.

Sector

Health Care

Industry

Biotechnology

Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult s...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Brainstorm Cell (BCLI) stock?

You can purchase shares of Brainstorm Cell (NASDAQ:BCLI) through any online brokerage.

View our list of the best stock brokerages

Who are Brainstorm Cell (BCLI) competitors?

Other companies in Brainstorm Cell’s space includes: Immuron (NASDAQ:IMRN), Tharimmune (NASDAQ:THAR), Acurx Pharmaceuticals (NASDAQ:ACXP), Synaptogenix (NASDAQ:SNPX) and Intensity Therapeutics (NASDAQ:INTS).

What is the forecast, or price target, for Brainstorm Cell (BCLI) stock?

Brainstorm Cell has a consensus price target of $2.00.

What is the current price for Brainstorm Cell (BCLI)?

The stock price for Brainstorm Cell (NASDAQ: BCLI) is $1.145 last updated June 30, 2025 at 1:30 PM EDT.

Does Brainstorm Cell (BCLI) pay a dividend?

There are no upcoming dividends for Brainstorm Cell.

When is Brainstorm Cell (NASDAQ:BCLI) reporting earnings?

Brainstorm Cell’s Q2 earnings are confirmed for Wednesday, August 13, 2025.

Is Brainstorm Cell (BCLI) going to split?

There is no upcoming split for Brainstorm Cell.

What sector and industry does Brainstorm Cell (BCLI) operate in?

Brainstorm Cell is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Brainstorm Cell Stock Price, Quotes and Forecasts

Brainstorm Cell (BCLI) Forecast